Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
CD Protein Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Keytruda
(pembrolizumab) / Merck (MSD)
Tecentriq
(atezolizumab) / Roche
Bavencio
(avelumab) / EMD Serono
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Kisqali
(ribociclib) / Novartis
Tyvyt
(sintilimab) / Eli Lilly
Loqtorzi
(toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Libtayo
(cemiplimab-rwlc) / Regeneron
Kaitanni
(cadonilimab) / Akesobio
Enweida
(envafolimab) / 3DMed, Tracon Pharma, Ascletis
Zynyz
(retifanlimab-dlwr) / Incyte
bintrafusp alfa
(M7824) / EMD Serono
spartalizumab
(PDR001) / Novartis
AiRuiKang
(dalpiciclib) / Jiangsu Hengrui Pharma
Anniko
(penpulimab) / Akesobio, Sino Biopharm
Rituxan
(rituximab) / Roche
balstilimab
(AGEN2034) / Agenus
Yutuo
(zimberelimab) / Arcus Biosci, Gilead
alvocidib
(DSP-2033) / Sumitomo Pharma
bempegaldesleukin
(NKTR-214) / Nektar Therap, BMS, Ono Pharma
Promacta
(eltrombopag) / Novartis
T3011
/ ImmVira Pharma
benmelstobart
(APL-502) / Apollomics
izuralimab
(XmAb23104) / Xencor
pepinemab
(VX15) / Vaccinex
Aibining
(geptanolimab) / Apollomics
Arenegyr
(NGR-hTNF) / AGC Biologics
Blincyto
(blinatumomab) / Astellas, Amgen
EGFR bi-armed autologous activated T cells
/ Barbara Ann Karmanos Cancer Institute
GI-101
/ GI Innovation
Mylotarg
(gemtuzumab ozogamicin) / UCB, PDL, Pfizer
Puyouheng
(pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med
TQB3616
/ Sino Biopharm
VG161
/ ViroGin Biotech
lorvotuzumab mertansine
(IMGN901) / AbbVie
oleclumab
(MEDI9447) / AstraZeneca
ontorpacept
(PF-07901800) / Pfizer
sotigalimab
(PYX-107) / Pyxis Oncology
zeluvalimab
(AMG 404) / Amgen
